Cooper Companies (COO) vs National Vision (EYE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Cooper Companies (COO) has outperformed National Vision (EYE) over the past year, losing 20.4% versus a loss of 39.5%. Over five years, COO leads with a -44.8% price change compared with -73.5% for EYE. Cooper Companies is the larger company by market cap ($10.41 billion vs $1.33 billion), about 7.8 times the size.
On valuation, Cooper Companies trades at a lower forward P/E (11.7x vs 13.9x for National Vision).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COO | EYE |
|---|---|---|
| Share price | $54.75 | $16.82 |
| Market cap | $10.41B | $1.33B |
| 1-day change | -2.98% | +0.48% |
| YTD return | -32.98% | -34.86% |
| 1-year return | -20.41% | -39.50% |
| 5-year return | -44.84% | -73.52% |
| P/E ratio (TTM) | 18.81 | 27.13 |
| Forward P/E | 11.67 | 13.92 |
| EPS (TTM) | $2.91 | $0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.09B | — |
| Revenue growth (YoY) | +5.06% | — |
| Net income (latest FY) | $374.90M | — |
| Gross margin | 65.54% | — |
| Operating margin | 16.69% | — |
| Net margin | 9.16% | — |
| 52-week high | $89.83 | $30.02 |
| 52-week low | $51.01 | $14.75 |
| Distance from 52-week high | -39.05% | -43.97% |
| Analyst consensus | hold | — |
| Avg. price target upside | +20.18% | — |
| Average volume | 3.11M | 2.14M |
| Shares outstanding | 190.16M | 79.07M |
| Employees | 15,000 | — |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cooper Companies is about 7.8 times larger than National Vision by market value ($10.41B vs $1.33B).
- COO has outperformed EYE by 19.1 percentage points over the past year.
- National Vision trades at a higher earnings multiple (27.1x vs 18.8x trailing P/E).
About Cooper Companies
COO stock →The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Health Care · Ophthalmic Goods · 15,000 employees
COO vs EYE FAQ
Which is bigger, Cooper Companies or National Vision?
Cooper Companies (COO) is larger, with a market capitalization of $10.41B compared with $1.33B for National Vision (EYE).
Which stock has performed better over the past year, COO or EYE?
COO returned -20.41% over the past 12 months, compared with -39.50% for EYE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, COO or EYE?
COO has the lower trailing P/E at 18.8, versus 27.1 for EYE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cooper Companies and National Vision in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.